Copy and paste this HTML to embed a link in your website
Paste link in email or IM
With GIBCO® Human Neural Stem Cells (H9-Derived), Life Technologies allows neuroscience researchers who do not have access to human embryonic stem cells or human tissues the use of the hNSC by removing the complicated isolation or derivation process. The cells are derived from the NIH approved H9 (WA09) human embryonic stem cells (hESCs). Each vial of GIBCO® hNSCs contains>1 million viable cells that can be propagated as an adherent culture in complete StemPro® NSC SFM. GIBCO® hNSCs retain their normal female human karyotype and their potential to differentiate into neurons and glial cells after multiple passages. GIBCO® Human Neural Stem Cells (H9-Derived) Kit comes with 1 vial of cells, KnockOut™ DMEM⁄F-12 Basal Medium, StemPro® Neural Supplement, FGF Basic and EGF Recombinant proteins for optimal growth and expansion as adherent cells on matrix or suspended neurospheres. Unlike tissue derived cells, hESC derived NSCs offer more consistent performance and minimize supply concerns. - Strong performance in adherent culture in a matrix and suspended neurosphere cultures. - Upon proliferation in StemPro® NSC SFM, >80% of the cells retain their undifferentiated Phenotype. Internal experiments have shown >90% of the cells retain their undifferentiated state. - Supports differentiation into Neurons, Astrocytes and Oligodendrocytes. - Sold as stand-alone cells and as a kit. Kit comes with cells and required reagents. - Minimal variability across lots and ready-to use system. Neural stem cells (NSCs) are self-renewing, multipotent stem cells of nervous system that can differentiate into neurons, oliogdendrocytes, and astrocytes. Multipotent NSCs can be derived from embryonic stem cells or isolated from fetal or adult central nervous system. NSCs are an invaluable resource not only for neuroscience and stem cell studies such as regulation of neurogenesis, neurotransmitter and receptor functions, and stem cell differentiation, but also for tissue engineering, cell and genetic therapy, and transplantation experiments to treat neurodegenerative diseases and neurological disorders.
If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Life Technologies websites. However, you can change your cookie settings at any time at the bottom of this page.
To access this page, please close your session and log into the PunchOut session again. You will need to provide an email address on the sign-in page.Please note if you are a punchout to supply center customer, and are viewing this message, your procurement system does not provide the required information to access this tool. Please contact your procurement system administrator for further instructions.